Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine and Albumin in Patients With Refractory Ascites
NCT04621617Phase 3Unknown
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Nov 2020
- Primary completion
- Dec 2021
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
01
Overview
Phase 3, randomised trial of midodrine and albumin (human) in ascites (3 arms), sponsored by Post Graduate Institute of Medical Education and Research. Primary endpoint: Number of patients with control of ascites at 1 year. Status: unknown.
02
Drugs
midodrinealbumin (human)
03
Conditions
ascites
Beyond the preview
Go deeper on NCT04621617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04621617.